What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?

Atherosclerosis
G R Thompson

Abstract

Analysis of trials which have investigated the effects of lowering low density lipoprotein (LDL) levels on coronary heart disease (CHD), as determined by changes on quantitative coronary angiography and in the incidence of cardiovascular events, suggests that the percentage decrease in LDL cholesterol provides a better index of outcome than does its absolute level on treatment. Additional data suggest that it may be advantageous to employ therapy which not only lowers LDL cholesterol but also decreases serum triglyceride and/or increases HDL cholesterol. These conclusions have important implications for future guidelines on CHD prevention.

Citations

Jan 5, 2002·Current Atherosclerosis Reports·Gilbert R ThompsonNeil J Stone
Jun 5, 2004·Atherosclerosis·Fernando Civeira, UNKNOWN International Panel on Management of Familial Hypercholesterolemia
Mar 6, 2003·Atherosclerosis·Gilbert R Thompson
Mar 21, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·R C CookA P Ignaszewski
Sep 10, 2003·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Carol M Mason
Apr 29, 1998·Current Opinion in Lipidology·A V Sussekov
Apr 29, 1998·Current Opinion in Lipidology·M Fisher, P H Groves
Aug 13, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Melissa A AustinSteve E Humphries
Oct 12, 2010·Current Opinion in Lipidology·Gilbert R ThompsonKlaus G Parhofer
Dec 30, 1998·Current Opinion in Lipidology·A D Marais
Feb 18, 2006·Journal of Interventional Cardiology·Cindy L Grines
Jan 15, 2010·Nursing in Critical Care·Phil Jevon
May 25, 2004·Expert Opinion on Pharmacotherapy·Herbert Schuster, Jonathan C Fox
Mar 7, 2003·Journal of Atherosclerosis and Thrombosis·Hiroyuki DaidaUNKNOWN Coronary Atherosclerosis and Lipid Research Group
Oct 5, 2002·Journal of Lipid Research·Bela F AsztalosErnst J Schaefer
Nov 13, 1998·Current Opinion in Lipidology·A V Sussekov
Aug 15, 2001·Clinical Cardiology·A G Olsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.